Drug Firms To Adjust Marketing Strategies For Former-Rx Drugs
This article was originally published in PharmAsia News
Executive Summary
Following the announcement by China's State FDA to switch 54 prescription drugs to over-the-counter drugs Feb 25, marketing strategy adjustments will be seen among affected drug makers such as Guilin Tianhe Pharmaceutical